DBVT Q2 2022 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$5M

Operating Income

-$25M

Net Income

-$23M

EPS (Diluted)

$-1.70

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$285M

Total Liabilities

$41M

Stockholders' Equity

$244M

Cash & Equivalents

$248M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$5M	-$7M	+26.0%
Operating Income	-$25M	-$30M	+14.9%
Net Income	-$23M	-$31M	+25.2%